Kolon Life Science Inc. (KOSDAQ: A102940)
Health Care · Pharmaceuticals · KR
₩14,250.00
-1.32% today · -54.8% 1Y
Kolon Life Science Inc. (KOSDAQ: A102940) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $138.76M.
Over the last twelve months the share price has lost 54.8%, trading between 13.21K and 72.70K.
Tweenvest scores Kolon Life Science Inc. across four factors: quality 58/100, value 63/100. Its strongest factor is value.
A102940 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $138.76M
- Revenue (TTM)
- $136.53M
- P/E
- 5.93
- EPS
- 2,403.02
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- ₩72,700.00
- 52-week low
- ₩13,210.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.09M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| REYON Pharmaceutical Co., Ltd.KOSE: A102460 | $140.25M | ₩10,280.00 | +1.58% |
| Whan In Pharm Co.,Ltd.KOSE: A016580 | $139.97M | ₩10,180.00 | -0.68% |
| Astena Holdings Co., Ltd.TSE: 8095 | $139.16M | ¥545.00 | -0.55% |
| Photocure ASAOB: PHO | $138.99M | Nkr49.40 | +0.82% |
| Hoechst Pakistan LimitedKASE: HPL | $137.99M | PKRs3,961.82 | -0.41% |
| Cuu Long Pharmaceutical Joint Stock CompanyHOSE: DCL | $137.70M | ₫48,800.00 | +4.95% |
| Kotra Industries BerhadKLSE: KOTRA | $137.58M | RM3.79 | -0.26% |
| BioSyent Inc.TSXV: RX | $135.93M | CA$17.15 | +1.39% |
Figures last refreshed Oct 11, 2026.